Innate immune defence in the human gastrointestinal tract. 2005

Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
Infectious Diseases and Microbiology, Institute of Child Health, University of College London, 30 Guilford Street, London WC1N 1EH, UK.

The mucosal surface of the gastrointestinal tract represents a major entry point and ecological niche for many microbes. It forms an important immune barrier, absorbing nutrients, whilst preventing invasion by organisms. Of the extra-ordinarily diverse species that comprise the microbial world, relatively few organisms are able to succeed in breaching this barrier in an otherwise healthy host. The production and secretion of antimicrobial peptides (AMPs) from surface epithelia and circulating immune cells are likely to play a key role in host protection and homeostasis. A number of these peptides are constitutively produced providing resident protection, whereas others are induced during infection and inflammation. In addition to directly eradicating microorganisms, it is becoming increasingly apparent that AMPs are multi-functional with diverse immuno-modulatory properties. This review focuses on three families of AMPs, defensins, cathelicidins, and lysozyme, and discusses their role in mucosal defence.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D041981 Gastrointestinal Tract Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS). Digestive Tract,GI Tract,Digestive Tracts,GI Tracts,Gastrointestinal Tracts
D054804 Cathelicidins Antimicrobial cationic peptides with a highly conserved amino terminal cathelin-like domain and a more variable carboxy terminal domain. They are initially synthesized as preproproteins and then cleaved. They are expressed in many tissues of humans and localized to EPITHELIAL CELLS. They kill nonviral pathogens by forming pores in membranes. ALL-38 Peptide,Antibacterial Peptide LL-37,Antimicrobial Peptide LL-37,Bac4 Protein, Bos taurus,CAP18 Lipopolysaccharide-Binding Protein,CATH-1 Protein,Cathelicidin,Cathelicidin 1,Cathelicidin Antimicrobial Peptide,Cathelicidin LL-37,Cathelicidin-1,Cathelin-Like Protein,Cathelin-Related Antimicrobial Peptide,LL-37 Antibacterial Peptide,LL-37 Peptide,Myeloid Cathelicidin 1 Protein, Equus caballus,Ropocamptide,eCATH-1,hCAP-18,CAP-18,CAP18,FA-LL-37,K9CATH,eCATH-1 protein, Equus caballus,ALL 38 Peptide,Antibacterial Peptide LL 37,Antibacterial Peptide, LL-37,Antimicrobial Peptide LL 37,Antimicrobial Peptide, Cathelin-Related,CAP 18,CAP18 Lipopolysaccharide Binding Protein,CATH 1 Protein,Cathelicidin LL 37,FA LL 37,LL 37 Antibacterial Peptide,LL 37 Peptide,LL-37, Antibacterial Peptide,LL-37, Antimicrobial Peptide,LL-37, Cathelicidin,Lipopolysaccharide-Binding Protein, CAP18,Peptide LL-37, Antibacterial,Peptide LL-37, Antimicrobial,Peptide, ALL-38,Peptide, Cathelin-Related Antimicrobial,Peptide, LL-37,Peptide, LL-37 Antibacterial,Protein, CAP18 Lipopolysaccharide-Binding,Protein, CATH-1,Protein, Cathelin-Like,eCATH 1,eCATH 1 protein, Equus caballus,hCAP 18
D023082 Defensins Family of antimicrobial peptides that have been identified in humans, animals, and plants. They are thought to play a role in host defenses against infections, inflammation, wound repair, and acquired immunity. Defensin
D023181 Antimicrobial Cationic Peptides Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane. Cationic Antimicrobial Peptide,Cationic Antimicrobial Peptides,Cationic Host Defense Peptides,Host Defense Peptide,Microbicidal Cationic Proteins,Amphipathic Cationic Antimicrobial Peptides,Host Defense Peptides,Antimicrobial Peptide, Cationic,Antimicrobial Peptides, Cationic,Cationic Peptides, Antimicrobial,Cationic Proteins, Microbicidal,Defense Peptide, Host,Defense Peptides, Host,Peptide, Cationic Antimicrobial,Peptide, Host Defense,Peptides, Antimicrobial Cationic,Peptides, Cationic Antimicrobial,Peptides, Host Defense,Proteins, Microbicidal Cationic

Related Publications

Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
December 1999, Gut,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
November 2003, Molecular immunology,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
January 2000, Acta physiologica Hungarica,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
January 1984, The Netherlands journal of medicine,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
June 2014, Clinics in perinatology,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
April 2021, Journal of applied microbiology,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
November 1991, Clinical and experimental immunology,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
May 2014, Revista espanola de enfermedades digestivas,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
March 2007, Current opinion in gastroenterology,
Rachel Dommett, and Matthias Zilbauer, and John T George, and Mona Bajaj-Elliott
July 2022, The FEBS journal,
Copied contents to your clipboard!